Correlation Between Thayer Ventures and Dermata Therapeutics

Can any of the company-specific risk be diversified away by investing in both Thayer Ventures and Dermata Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Thayer Ventures and Dermata Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Thayer Ventures Acquisition and Dermata Therapeutics Warrant, you can compare the effects of market volatilities on Thayer Ventures and Dermata Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Thayer Ventures with a short position of Dermata Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Thayer Ventures and Dermata Therapeutics.

Diversification Opportunities for Thayer Ventures and Dermata Therapeutics

-0.07

Correlation Coefficient

Thayer Ventures  Dermata Therapeutics

Good diversification

The 3 months correlation between Thayer and Dermata is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Thayer Ventures Acquisition and Dermata Therapeutics Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dermata Therapeutics and Thayer Ventures is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Thayer Ventures Acquisition are associated (or correlated) with Dermata Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dermata Therapeutics has no effect on the direction of Thayer Ventures i.e., Thayer Ventures and Dermata Therapeutics go up and down completely randomly.

Pair Corralation between Thayer Ventures and Dermata Therapeutics

Assuming the 90 days horizon Thayer Ventures is expected to generate 12.93 times less return on investment than Dermata Therapeutics. But when comparing it to its historical volatility, Thayer Ventures Acquisition is 6.33 times less risky than Dermata Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Dermata Therapeutics Warrant is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  1.46  in Dermata Therapeutics Warrant on September 20, 2024 and sell it today you would lose (0.01) from holding Dermata Therapeutics Warrant or give up 0.68% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	56.65%
Values	Daily Returns

Thayer Ventures Acquisition  vs.  Dermata Therapeutics Warrant

Thayer Ventures Acqu

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Thayer Ventures Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Dermata Therapeutics

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Dermata Therapeutics Warrant are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Dermata Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Thayer Ventures and Dermata Therapeutics

The main advantage of trading using opposite Thayer Ventures and Dermata Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Thayer Ventures position performs unexpectedly, Dermata Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermata Therapeutics will offset losses from the drop in Dermata Therapeutics' long position.

The idea behind Thayer Ventures Acquisition and Dermata Therapeutics Warrant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.